Years of Potential Life Lost (YPLL), the Key Metric in Strategic Planning for Chronic Kidney Disease Care
DOI:
https://doi.org/10.61882/ijkd.19.06.9371Downloads
References
1. Gardner JW, Sanborn J S. Years of potential life lost (YPLL)-what does it measure? Epidemiology. 1990; 4:322-9.
2. Gardner JW; Sanborn JS (1976). “Years of potential
life lost (YPLL)-what does it measure”. Comparative Biochemistry and Physiology. A, Comparative Physiology. 1976; 53: 323-6.
3. https://web.archive.org/web/20110706164746/http://www. apheo.ca/index.php?pid=190 (last visited, 2025/19/11)
4. https://en.wikipedia.org/wiki/Years_of_potential_life_ lost#cite_note-homes-1 (last visited, 2025/19/11)
5. GBD 2023 Chronic Kidney Disease Collaborators. Global, regional, and national burden of chronic kidney disease in adults, 1990-2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023. Lancet. 2025, Nov 22;406(10518):2461-2482
6. https://www.healthdata.org/news-events/newsroom/news-releases/chronic-kidney-disease-has-more-doubled-1990-now-affecting (last visited, 2025/19/11)
7. https://www.yalemedicine.org/news/why-is-chronic-kidney-disease-ckd-on-the-rise, (last visited, 2025/19/11)
8. Mirzaei M, Nourimajalan N, Morovati H, Askarishahi M, Roya Hemayati R. Prevalence and predisposing factors of chronic kidney disease in Yazd city; a population-based study. Renal Inj Prev. 2022; 11: e01
9. Kheirandish M, Eftekhar E, Azarbad A, et al. Prevalence of Chronic Kidney Disease and Associated Factors among the Diabetic and Prediabetic Population in the Bandare-Kong Cohort Study; A Population-Based Study. Arch Iran Med. 2024; 27: 470-478.
10. Khajehdehi P, Malekmakan L, Pakfetrat M, RoozbehJ, Sayadi M. Prevalence of Chronic Kidney Disease and Its Contributing Risk Factors in Southern Iran: A Cross-sectional Adult Population-based Study. Iran J Kidney Dis 2014; 8:109-15
11. Sepanlou SG, Hamid Barahimi H, Iraj Najafi N et al. Prevalence and determinants of chronic kidney disease in northeast of Iran: Results of the Golestan cohort study. PLoS One. 2017 3;12: e0176540.
12. Bouya S, Abbas Balouchi A, Rafiemanesh H, Hesaraki M. Prevalence of Chronic Kidney Disease in Iranian General Population: A Meta-Analysis and Systematic Review. Ther Apher Dial. 2018; 22: 594-599
13. Shahbazi F, Doosti-Irani A, Soltanian A, Poorolajal J. National trends and projection of chronic kidney disease incidence according to etiology from 1990 to 2030 in Iran: a Bayesian age-period-cohort modeling study. Epidemiol Health 2023; 45: 1 -10
14. Karam S, Amouzegar A, Alshamsi IR, et al. Capacity for the management of kidney failure in the International Society of Nephrology Middle East region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA). Kidney Int Suppl (2011). 2024; 13:57-70
